SPECIALIZED CRO – DURHAM, NC
Neuropsychiatry-native, trial-ready.
Qortical Clinical Partners is a founder-led contract research organization dedicated to developing transformative treatments for psychiatric and neurological conditions — with deep expertise in neurostimulation and mental health populations
OUR MISSION
Precision research for a complex field
We exist at the intersection of neuroscience and clinical execution. Our mission is to accelerate the development of safe, effective neurotechnology-based treatments for mental illness — bringing rigor, speed, and specialized expertise to every engagement.
Founded in 2025 and headquartered in Durham, North Carolina, QCP combines the scientific depth of academic research with the agility and accountability of a purpose-built clinical research organization.
SPECIALIZED FOCUS
We concentrate on psychiatric and neurological populations, allowing us to build depth of expertise that general CROs cannot replicate. This translates directly to better protocol design, faster recruitment, and cleaner data.
REGULATORY INTEGRITY
We deliver the scientific rigor and regulatory precision essential in a field under growing scrutiny, maintaining the highest standards for documentation, compliance, and data quality at every stage of trial execution.
FOUNDER-LED EXECUTION
Every engagement benefits from direct involvement of our founding team — PhDs, clinical experts, and regulatory specialists who have led complex trials and understand what it takes to generate compelling, defensible evidence.
SPEED WITHOUT COMPROMISE
As a boutique organization, we move with the agility that sponsors need — without the bureaucratic overhead of legacy CROs or the timeline uncertainty of academic institutions.
WHAT WE DO
Full-spectrum clinical research support
From early regulatory strategy through pivotal trial execution and post-market scientific dissemination, QCP provides the specialized expertise, operational infrastructure, and scientific credibility that neurotechnology sponsors need to succeed.
01
Clinical Site & Trial Execution
QCP operates as a dedicated clinical research site investigating medical devices for psychiatric applications, with deep expertise in anxiety, depression, and related conditions. We conduct trials with the efficiency and accountability of a specialized site partner.
02
Clinical Trial Management
End-to-end project coordination and multi-site management for pivotal and early-phase trials. We serve as the operational hub — managing sites, timelines, vendors, and sponsor communications so that your study stays on track.
03
Protocol & Scientific Consultation
Trial design, endpoint selection, and scientific rationale development optimized for the unique demands of mental health and neuromodulation research. We bridge the gap between bench science and clinical evidence generation.
04
Data Analysis & Scientific Dissemination
Sophisticated statistical analysis, manuscript preparation, and evidence strategy for completed studies. We translate your clinical data into peer-reviewed publications, regulatory submissions, and market-facing scientific narratives.
CURRENTLY ENROLLING
Participate in a clinical trial
QCP is actively enrolling participants in clinical studies investigating novel non-invasive brain stimulation interventions for mental health conditions. If you or someone you know may be interested in participating, we encourage you to reach out.
Participation in research studies is entirely voluntary. All studies conducted at QCP are reviewed and approved by an Institutional Review Board (IRB).
If you’d like to be contacted by a member of our team to learn more about study participation opportunities at QCP, please provide your information below and we will get in touch with you.
FOUNDER TEAM
Led by experts, built for the field
QCP’s founding team unites deep academic expertise in neuroscience, clinical trial operations, scientific affairs, and regulatory compliance — offering clients direct access to seasoned professionals who have built and led programs like theirs.
FLAVIO FROHLICH, PHD MSC ETH MA
Co-Founder
Internationally recognized expert in non-invasive brain stimulation with 25+ years of neurotechnology development experience. Professor of Psychiatry, entrepreneur, and professional coach.
GRACE ROSS, PHD
Co-Founder, President and VP Scientific Affairs
Leads scientific strategy, protocol development, data analytics, and clinical data interpretation. Expertise spanning preclinical mechanistic brain stimulation studies to human EEG investigations linking neurophysiology with clinical outcomes.
ZACHARY STEWART, BA
Co-Founder, Secretary, and VP Clinical Operations
Oversees trial management, site coordination, recruitment, and sponsor relationships. Extensive experience leading randomized controlled trials in anxiety, depression, substance use disorder, and novel brain stimulation interventions.
ANITA FROHLICH, MSW LLM
Co-Founder, VP Community Engagement and Health Equity
Brings extensive experience in mental health and neurology clinical trials, with particular expertise in community engagement, health equity, and regulatory compliance. At QCP, Anita leads community relationship-building, public mission narrative, and DEI practices across recruitment, consent, and participant communication.
WHERE WE ARE
Based in Durham, NC
HEADQUARTERS AND CLINICAL SITE
3604 Shannon Road, Suite 105
Durham, NC 27707
CLINICAL RESEARCH REACH
QCP supports multi-site pivotal trials with experienced monitoring and coordination capabilities across academic medical centers and community clinical research sites nationwide
CONTACT
info@qortical.com
GOVERNING JURISDICTION
Qortical Clinical Partners, Inc. is incorporated and operates under the laws of the State of North Carolina.